Plain language summary of survival and treatment patterns among patients with warm autoimmune hemolytic anemia in Sweden

Le résumé fourni par la source

Plain Language SummaryWhat is this summary about?This summary describes results from a study of Swedish patients with warm autoimmune hemolytic anemia (wAIHA), including those with primary wAIHA and secondary wAIHA, where another condition, like cancer, autoimmune disease, or a weakened immune system, may be part of the development of wAIHA. Researchers also did a second analysis, called a sensitivity analysis, to increase patient numbers by adding patients with the less specific diagnosis of autoimmune hemolytic anemia (AIHA).What were the results?In the analysis of 292 patients with wAIHA, the average age was 66 years and the most common other health problems were hypertension, depression, and diabetes. Compared with primary wAIHA, patients with secondary wAIHA were older and had other health conditions more often. Nearly all patients with wAIHA received oral corticosteroids (OCS) as the first medicine after diagnosis. OCS were more common in secondary wAIHA (95%) than in primary wAIHA (83%). After OCS, 11% of patients received nonsteroidal immunosuppressants (NSIS) and 4% of patients had a splenectomy. On average, patients with secondary wAIHA lived for a shorter time compared with those with primary wAIHA. However, after considering differences in age, sex, and other health problems, mortality risk was similar in both groups. The second analysis included 1791 patients with wAIHA or AIHA who received OCS or NSIS.What do the results mean?In this analysis, patients with secondary wAIHA had 25% higher mortality compared with those with primary wAIHA, even after considering all differences. In the first analysis, patients in the long-term OCS group had a shorter median overall survival compared with patients in the short-term OCS group. After considering differences in age, sex, and other health problems, mortality risk was similar in both groups regardless of the duration of OCS use. However, in the second analysis, patients receiving long term OCS had 45% higher mortality compared with patients receiving short-term OCS, even after considering all differences. Results from the second analysis show that Swedish patients with wAIHA lived for a shorter time if they had other health conditions or received OCS for longer. These findings show the seriousness of the disease and the need for better medicines.How to say (download PDF and double click sound icon to play sound)…Warm autoimmune hemolytic anemia (wAIHA): warm aa-tow-ih-myoon hee-muh-lih-tik uh-nee-mee-uh (way-hah)Corticosteroids: kor-ti-kow-steh-roydzWarm autoimmune hemolytic anemia (wAIHA): A rare, potentially life-threatening condition that happens when the person’s antibodies (autoantibodies) attack and destroy their own red blood cells (RBCs) at body temperature.Primary warm autoimmune hemolytic anemia (wAIHA): wAIHA with an unknown cause.Secondary warm autoimmune hemolytic anemia (wAIHA): wAIHA linked to another health condition, such as certain forms of blood cancer (for example, chronic lymphocytic leukemia) or an autoimmune disease (for example, systemic lupus erythematosus).Autoimmune disease: A condition where the body’s immune system attacks its own healthy cells and causes damage.Immune system: The body’s natural defense system against infection.Sensitivity analysis: An additional method of analysis to confirm the reliability of research findings.Autoimmune hemolytic anemia (AIHA): A rare, potentially life-threatening condition that occurs when the person’s antibodies (autoantibodies) attack and destroy their own red blood cells (RBCs), resulting in anemia (the body’s organs not getting enough oxygen).Hypertension: High blood pressure.Diabetes: A condition defined by high blood sugar levels if not treated.Oral corticosteroids (OCS): OCS are usually the first treatment for wAIHA since they reduce inflammation and suppress the immune system. They include dexamethasone, methylprednisolone, prednisolone, and prednisone. However, because they affect the immune system, they can also lead to serious side effects.Nonsteroidal immunosuppressant (NSIS): Medicine that reduces the activity of the immune system without using steroids.Splenectomy: Surgery to remove the spleen. Red blood cells (RBCs) are destroyed in the spleen. Therefore, removal of the spleen may decrease the destruction of RBCs in patients with wAIHA.Mortality: Death from a certain condition.Long-term oral corticosteroid (OCS) group: Patients who took OCS for 3 months or more.Median overall survival: The amount of time after patients received a diagnosis when half of the patients in the group are still alive.Short-term oral corticosteroid (OCS) group: Patients who took OCS for less than 3 months.This is an abstract of the Plain Language Summary of Publication article.View the full Plain Language Summary PDF of this article to read the full-textLink to original article here

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.